Cresco Labs Inc (CRLBF) fair value: what the stock is really worth
As of Nov 18, 2026: fair value (intrinsic value) of Cresco Labs Inc stock $1.38, price $0.46, upside +200.0%, quality 31 out of 100. Rating: strongly undervalued. Calculated from audited financials with 10 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Cresco Labs Inc
CRLBF · USCheap (67% below fair value), but weak company and falling price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 19, 2026.
How to read this chart
60‑month range $0.4320 – $10.08 · fair‑value band $0.4794 – $2.60 · the $0.4600 price screens below the $1.38 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 19, 2026.
Every Wednesday you see whether Cresco Labs is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
Show moreShow less
It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand.
The company is headquartered in Chicago, Illinois.
Stock analysis
Cresco Labs Inc (CRLBF) currently trades at $0.4600, while our model-based Fair Value estimate is $1.38, implying the stock looks roughly 67% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of $2.66 per share, and 10 of the 10 models we run sit above the $0.4600 price.
Bear case: the Growth DCF group reads lowest at $1.43, and 0 of the 10 models stay below the price. Data coverage for this calculation is low.
Scenario range: $0.4794 (bear) to $2.60 (bull), the price of $0.4600 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 31/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Cresco Labs Inc reported revenue of $656M in FY2025 versus $822M in FY2021, a compound −5.5%/yr. Reported net income was −$135M in FY2025.
Key figures
Market cap $170M Micro · P/S ratio 0.35 · EPS (TTM) $−0.3900 · Net margin −20.6% · Return on equity −36.1% · Return on assets (EBIT) 5.5% (5-year average) · Operating margin 7.7% · Revenue (TTM) $651M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 16 out of 100 (medium confidence).
What moves the price
The share trades about 76% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 200%, CRLBF screens cheaper than that median.
Fair Value models
All 10 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch CRLBF, get fair value alerts →
Earlier news
- Cresco Labs reports Q3 results
- Cresco Labs Advances Innovation Pipeline with High Supply SLIPS and Wonder THC Drink Mixes
Compare Cresco Labs Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 608 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Price/FCF by industry
- Debt-to-equity by industry
- PEG screener for stocks with fair value
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $85.57 | $113.53 | +33% | vs CRLBF |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥46.90 | ¥52.43 | +12% | vs CRLBF |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,872 | ₹1,983 | +6% | vs CRLBF |
| Haleon plc HLN | $9.08 | $8.47 | −7% | vs CRLBF |
| Merck KGaA MRK | €149.50 | €108.83 | −27% | vs CRLBF |
| Galderma Group GALD | CHF 187.55 | CHF 112.46 | −40% | vs CRLBF |
| Takeda Pharmaceutical Company TAK | $21.27 | $11.23 | −47% | vs CRLBF |
| Sandoz Group SDZ | CHF 81.50 | CHF 41.06 | −50% | vs CRLBF |
| Teva Pharmaceutical Industries Limited TEVA | $42.23 | $20.74 | −51% | vs CRLBF |
| Divi's Laboratories Limited DIVISLAB | ₹11,049 | ₹1,567 | −86% | vs CRLBF |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Cresco Labs Inc (CRLBF) overvalued or undervalued?
What is the fair value of CRLBF?
What is the quality score of CRLBF?
What is the price target for Cresco Labs Inc (CRLBF)?
What is the Cresco Labs Inc stock forecast for 2026?
What is the revenue of Cresco Labs Inc (CRLBF)?
What growth is priced into Cresco Labs Inc (CRLBF)?
What discount rate (WACC) does the fair value of CRLBF use?
What is a reverse DCF?
How much growth has Cresco Labs Inc (CRLBF) delivered so far?
How fast is the sector of Cresco Labs Inc (CRLBF) growing?
What is the free cash flow yield of Cresco Labs Inc (CRLBF)?
What is the intrinsic value of Cresco Labs Inc (CRLBF)?
Is Cresco Labs Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of CRLBF?
How much is Cresco Labs Inc worth?
What do the bullish and bearish scenarios say about CRLBF?
How solid is the balance sheet of Cresco Labs Inc (CRLBF)?
How far is CRLBF from its 52-week high?
Which stocks are comparable to Cresco Labs Inc?
Is Cresco Labs Inc stock attractive at the current price?
How is the fair value of CRLBF calculated?
Is it still worth investing in stocks now?
What is the share price of Cresco Labs Inc (CRLBF)?
What should I pay attention to with Cresco Labs Inc right now?
Key figures of Cresco Labs Inc
How large is the market capitalisation of Cresco Labs Inc (CRLBF)?
What is the P/S ratio of Cresco Labs Inc (CRLBF)?
What are the earnings per share of Cresco Labs Inc (CRLBF)?
What is the net margin of Cresco Labs Inc (CRLBF)?
What is the return on equity of Cresco Labs Inc (CRLBF)?
What is the EBIT return on assets of Cresco Labs Inc (CRLBF)?
What is the operating margin of Cresco Labs Inc (CRLBF)?
How fast is revenue growing at Cresco Labs Inc (CRLBF)?
How fast are earnings growing at Cresco Labs Inc (CRLBF)?
How much net debt does Cresco Labs Inc (CRLBF) carry?
Watch Cresco Labs Inc in the live analysis
One click puts Cresco Labs Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.